Degree | Type | Year | Semester |
---|---|---|---|
2502442 Medicine | OB | 5 | 0 |
There has been changes in the teaching team of the subject, the teacher Josep Torrent Farnell is replaced by teacher Rosa Maria Antonijoan Arbós (RosaMaria.Antonijoan@uab.cat)
You can check it through this link. To consult the language you will need to enter the CODE of the subject. Please note that this information is provisional until 30 November 2023.
It is absolutely necessary to have achieved sufficient knowledge in general pharmacology.
It is advisable that the student has achieved basic skills in pathophysiology and clinical semiology.
The subject is programmed in the fifth year of the Degree in Medicine, when knowledge of general pathology and of the etiology, clinic and diagnosis of the main diseases and syndromes has already been achieved. The student already has a knowledge of the principles of general pharmacology and knows most groups of medicines, their mechanism of action and their main desired and unwanted effects.
The educational objectives of the subject are to provide the elements to learn how to select the most appropriate treatment for each individual patient through a reasoned process that involves assessing the efficacy, safety, convenience and cost of each available option. Additionally, it aims to raise awareness of the dynamics of medicines in society, from the search for new molecules to approval and funding decisions by health authorities, and post-marketing pharmacovigilance, as well as providing the necessary elements to be able to critically assess the information on the new medicines that are being marketed.
The theoretical knowledge of the subject is complemented by practical activities on reasoned prescription and administration of medicines, selection of treatments in patients with the most frequent pathologies seen in primary care, critical evaluation of information on new medicines, and identification and assessment of suspected adverse reactions to medicines in specific patients.
Competences
• Communicate clearly, both orally and in writing, with other professionals and the media.
• Communicate effectively and clearly, both orally and in writing, with patients, relatives and companions, to facilitate their decision-making, informed consent and compliance with prescriptions.
• Demonstrate that you understand the basics of action, indications, effectiveness and benefit-risk ratio of therapeutic interventions, based on the available scientific evidence.
• Establish diagnosis, prognosis and treatment supporting decisions with the best possible evidence and a multidisciplinary approach based on the patient's needs and involving all members of the health team, as well as the family and social environment.
• Formulate hypotheses and collect and critically assess information for problem solving following the scientific method.
• Indicate the most appropriate therapy for the most prevalent acute and chronic processes, as well as for terminally ill patients.
• Maintain and update your professional competence, giving special importance to independent learning of new knowledge and techniques and to motivation for quality.
• Organize and properly plan the workload and time in professional activities.
• Recognize the determinants of population health, both genetic and those dependent on sex, lifestyle, demography, environmental, social, economic, psychological and cultural factors.
• Have the ability to work in an international context.
• Critically evaluate and use clinical and biomedical information sources to obtain, organize, interpret and communicate scientific and health information
Distributive blocks
1. General clinical pharmacology. Medicines for human use. Information sources. New drug research methods. The clinical trial. Methodological and ethical aspects. Evaluation of the effects of medicines. Adverse reactions and interactions. Use of medicines in special populations (pregnancy, childhood and old age; kidney and heart failure). Social pharmacology. Principles of pharmacoeconomics.
2. Specific clinical pharmacology - Rational use of medicines in the main pathological processes treated in primary care: selection and prescription of medicines, and other therapeutic considerations.
Directed activities: Theoretical classes (28 hours)
Theoretical classes - General part
T1: Introduction to clinical and therapeutic pharmacology. Medicines for human use.
T2: Sources of information in clinical pharmacology.
T3: Development of medicines: scientific, methodological, bioethical and legal aspects. placebo effect
T4: Clinical trials of medicines and their methodological basis (1).
T5: Clinical trials of medicines and their methodological basis (2).
T6: Clinical pharmacokinetics and dose adjustment. Evaluation of the action and effect of medicines.
T7: Pharmacological interactions of clinical interest and interactions between medicines and other compounds.
T8: Adverse drug reactions and pharmacovigilance.
T9: Pharmacoepidemiology.
T10: Use of medicines in the health system and its economic implications.
T11: Abuse and dependence on medicines and drugs.
T12: Clinical pharmacology in pregnancy and childhood.
T13: Clinical pharmacology in the elderly.
T14: Clinical pharmacology of renal, hepatic and other pathological processes.
T15: Pharmacogenetics.
T16: Good practices in prescribing medicines. Legal regulation of prescription and types of prescriptions: prescriptions and medical orders. co-payment
Theoretical classes - Specific part
T17: Introduction to the rational use of antibiotics.
T18: Therapeutics in cardiovascular diseases.
T19: Therapeutics of psychiatric pathologies.
T20: Introduction to pain management.
T21: Therapeutics in respiratory pathology.
T22: Therapeutics in digestive pathology.
T23: Therapeutics in genitourinary pathology.
T22: Regulation of fertility.
T25: Therapeutics in osteoarticular pathology.
T26: The oncological patient in primary care.
T27: Principles of selection and appropriate use of medicines used in elderly patients.
T28: Summary of the course and conclusions
Directed activities: Clinical case seminars (SCC) (12 seminar sessions, 34 hours)
SCC - General part
SCC 1: Information sources in Clinical Pharmacology. (2 hours). Resources: Internet access. Books and articles.
SCC 2: Clinical trials of medicines and their methodological bases. placebo effect (3 hours). Resources: Article to read and comment. Q
SCC 3: Adverse drug reactions and pharmacovigilance. (3 hours). Resources: CC-Q
SCC 4: The process of selecting medicines. (3 hours) Resources: CC-Q
SCC 5: Prescription of medicines and the health system. Advertising and media. (3 hours) Resources: Newspaper News. Q
SCC 6: Alternative medicines (2 hours) Resources: CC-GT-Q
SCC - Specific part
SCC 7: Antibiotics (urinary infection and pneumonia). (3 hours) Resources: CC-Q
SCC 8: Cardiovascular (3 hours) Resources: CC-GT-Q
SCC 9: Respiratory (3 hours) Resources: CC-GT-Q
SCC 10: Diabetes (3 hours) Resources: CC-GT-Q
SCC 11: Psychiatric diseases and dementias (3 hours) Resources: CC-GT-Q
SCC 12: Pain (3 hours) Resources: CC-GT-Q
Directed activities – Advanced clinical simulation practices (PSCA) (2 sessions, 5 hours)
PSCA 1: Prescription of medicines and information to the patient. Administration and administration instructions. Dose adjustment. (2 hours) Resources: AER
PSCA 2: Pharmacological history and assessment of treatment adherence. Review of the medication plan and the achievement of therapeutic goals. Reconciliation and prescription of medication. (3 hours) Resources: AER
T = Theoretical class (1 hour). SCC = Clinical Cases Seminar (2 or 3 hours). PPT = Powerpoint Presentation; C-GT-Q = Clinical case, treatment guidelines and questionnaire. PSCA = Advanced clinical simulation practice (in humans) (2 or 3 hours) AER: Structured assessment with rubric.
General methodology:
Subject credits: 6 ECTS = 150 hours
AUTONOMOUS WORK (50% total = 75 hours).
Comprehensive reading of texts and articles, study and creation of diagrams, summary and conceptual assimilation of the contents.
Prior preparation of the clinical case seminars, with reading of the preparatory materials and, when appropriate (according to what is established by each unit) preparation of the presentations and assignments.
DIRECTED LEARNING: 67 hours
Theory (TE typology). Group Size: full course group. 28 scheduled sessions (1 hour per session).
Clinical Case Seminar Practices (SCC) Group size: 20 students. Scheduled sessions: 10 sessions of 3 hours and 2 sessions of 2 hours. The students, in small groups, will discuss typical clinical cases, under the direction of a tutor.
Advanced clinical simulation practices: PSCA typology (12 students per group). Scheduled sessions: 2 sessions (1 2-hour session and 1 3-hour session). Practices simulating clinical situations that require the presence of 2 teachers.
EVALUATION (5% total = 8 hours): 2 partial exams and 1 final synthesis exam; continuous evaluation of the seminars.
Annotation: Within the schedule set by the centre or degree programme, 15 minutes of one class will be reserved for students to evaluate their lecturers and their courses or modules through questionnaires.
Title | Hours | ECTS | Learning Outcomes |
---|---|---|---|
Type: Directed | |||
Advanced clinical simulation | 5 | 0.2 | 3, 4, 10, 14, 16, 25, 27, 28, 29, 35, 39, 40, 41 |
Clinical Case Seminars | 34 | 1.36 | 3, 4, 10, 11, 13, 17, 22, 23, 24, 25, 27, 28, 31, 36, 38, 39, 41 |
Theory sessions | 28 | 1.12 | 1, 2, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 18, 19, 20, 21, 22, 23, 25, 26, 28, 30, 31, 32, 33, 34, 36, 37, 38, 40 |
Type: Autonomous | |||
Autonomous learning | 75 | 3 | 1, 2, 3, 5, 7, 8, 9, 10, 12, 13, 14, 15, 17, 18, 19, 21, 23, 24, 26, 28, 30, 31, 32, 33, 34, 36, 38, 39, 41 |
The evaluation system will be based on a theoretical part (70% of the final result) and a practical part (30% of the final result).
Theoretical part:
Two partial theoretical exams will be scheduled, which may be releasing of subject if the score obtained is higher than 5.0. A final exam will consist of two parts, one for each partial; it will be possible to recover those parts that have not been released in the partial exams.
Practical part:
Attendance at 80% of SCCs and PSCAs is mandatory. In accordance with the particularities of each teaching Unit, the practices/seminars may be evaluated continuously. Continuous evaluation will be specified in the program of each unit; complementary activities may be applicable.
The student who has not passed the partial exams and/or having fulfilled the required attendance has not passed the practical part, can access the final test which contains a theoretical part and a practical part.
Final qualification
The final grade is the weighted average of the theoretical knowledge (70%) and the evaluation of the SCC and PSCA (30%). It will not be possible calculate average scores between the theoretical assessment and the practical assessment unless a minimum score of 5/10 is obtained in both assessments. In case of not being able to do the average, the final qualification will correspond to the lowest quantitative value among those obtained in the theoretical and practical evaluations.
When the student does not attend the scheduled partial tests or final test, it will be informed as non-evaluable.
This subject/module does not apply the single evaluation system.
Title | Weighting | Hours | ECTS | Learning Outcomes |
---|---|---|---|---|
Continued evaluation through practical cases and problem solving | 30% | 4 | 0.16 | 3, 4, 10, 11, 13, 14, 16, 17, 22, 23, 24, 25, 27, 28, 29, 31, 35, 36, 38, 39, 40, 41 |
Written tests using objective measurements | 70% | 4 | 0.16 | 1, 2, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 25, 26, 28, 30, 31, 32, 33, 34, 36, 37, 38, 40 |
No specific software will be used.